AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
5.63
-0.35 (-5.85%)
Sep 9, 2026, 3:30 PM EDT - Market open
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $212.46 million as of September 9, 2026. Its market cap has increased by 553.34% in one year.
Market Cap
212.46M
Enterprise Value
134.07M
1-Year Change
553.34%
Ranking
Category
Stock Price
$5.63
ChartMarket Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $212.46M, a decrease of -24.42%. That is a compound annual growth rate of -6.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 212.46M | 580.11% |
| Dec 31, 2025 | 31.24M | -24.24% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
| Mar 25, 2022 | 281.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Protara Therapeutics | 232.84M |
| Acumen Pharmaceuticals | 229.97M |
| Sol-Gel Technologies | 227.61M |
| Tonix Pharmaceuticals Holding | 225.36M |
| Keros Therapeutics | 224.44M |
| Coherus Oncology | 219.39M |
| Armata Pharmaceuticals | 217.14M |
| Voyager Therapeutics | 216.28M |